Browsing by Author Universita degli Studi di Cagliari

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 4 to 7 of 7 < previous 
Issue DateTitleAuthor(s)
18-Jun-2015Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadYesim Aydinok; Antonis Kattamis; M. Domenica Cappellini; Amal El-Beshlawy; Raffaella Origa; Mohsen Elalfy; Yurdanur Kilinç; Silverio Perrotta; Zeynep Karakas; Vip Viprakasit; Dany Habr; Niculae Constantinovici; Junwu Shen; John B. Porter; Ege University Medical School; University of Athens; Universita degli Studi di Milano; Cairo University; Universita degli Studi di Cagliari; Ain Shams University; Cukurova Universitesi; Child and of General and Specialist Surgery; Istanbul Tip Fakultesi; Mahidol University; Novartis Pharmaceuticals; Novartis International AG; UCL Cancer Institute
12-Apr-2011On T2* magnetic resonance and cardiac ironJohn Paul Carpenter; Taigang He; Paul Kirk; Michael Roughton; Lisa J. Anderson; Sofia V. De Noronha; Mary N. Sheppard; John B. Porter; J. Malcolm Walker; John C. Wood; Renzo Galanello; Gianluca Forni; Gualtiero Catani; Gildo Matta; Suthat Fucharoen; Adam Fleming; Michael J. House; Greg Black; David N. Firmin; Timothy G. St. Pierre; Dudley J. Pennell; National Health Service; National Heart and Lung Institute; St George's Hospital, London; UCL; Children's Hospital Los Angeles; Universita degli Studi di Cagliari; E.O. Ospedali Galliera; Azienda Ospedaliera Brotzu; Mahidol University; University of Western Australia
5-Apr-2012A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overloadEllis J. Neufeld; Renzo Galanello; Vip Viprakasit; Yesim Aydinok; Antonio Piga; Paul Harmatz; Gian Luca Forni; Farrukh T. Shah; Rachael F. Grace; John B. Porter; John C. Wood; Jennifer Peppe; Amber Jones; Hugh Young Rienhoff; Harvard University; Universita degli Studi di Cagliari; Mahidol University; Ege University Medical School; Scienze Cliniche e Biologiche; UCSF Benioff Children's Hospital Oakland; E.O. Ospedali Galliera; Whittington Hospital; UCL; Children's Hospital Los Angeles; FerroKin BioSciences, Inc.
1-Apr-2008The VIZIER project: Preparedness against pathogenic RNA virusesB. Coutard; A. E. Gorbalenya; E. J. Snijder; A. M. Leontovich; A. Poupon; X. De Lamballerie; R. Charrel; E. A. Gould; S. Gunther; H. Norder; B. Klempa; H. Bourhy; J. Rohayem; E. L'hermite; P. Nordlund; D. I. Stuart; R. J. Owens; J. M. Grimes; P. A. Tucker; M. Bolognesi; A. Mattevi; M. Coll; T. A. Jones; J. Åqvist; T. Unge; R. Hilgenfeld; G. Bricogne; J. Neyts; P. La Colla; G. Puerstinger; J. P. Gonzalez; E. Leroy; C. Cambillau; J. L. Romette; B. Canard; Universite de Provence Aix-Marseille 1; CNRS Centre National de la Recherche Scientifique; Center of Infectious Diseases; Faculte de Medecine de Marseille Universite de la Mediterranee; Centre for Ecology &amp; Hydrology; Swedish Institute for Infectious Disease Control; Institute of Virology Slovak Academy of Sciences; Institut Pasteur, Paris; Bernhard Nocht Institut fur Tropenmedizin Hamburg; Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus; BioXtal; University of Oxford; Deutsche Elektronen-Synchrotron; Universita degli Studi di Milano; Universita degli Studi di Pavia; CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Global Phasing Ltd; Uppsala Biomedicinska Centrum; Universität zu Lübeck; KU Leuven; Universita degli Studi di Cagliari; Mahidol University; IRD-R178; University of Innsbruck; Lomonosov Moscow State University; Stockholms universitet